SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-063710
Filing Date
2018-12-20
Accepted
2018-12-20 17:24:12
Documents
2
Period of Report
2018-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1669
2 POA DOCUMENT poa.txt EX-24.3_822242 4004
  Complete submission text file 0001209191-18-063710.txt   7124
Mailing Address 240 LEIGH FARM ROAD DURHAM NC 27707
Business Address 240 LEIGH FARM ROAD DURHAM NC 27707 919-806-4487
Dova Pharmaceuticals Inc. (Issuer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707
Business Address
Hoitt Jason (Reporting) CIK: 0001762572 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38135 | Film No.: 181247018